Market Introduction
The starch softgel capsules are usually derived from natural sources and used as nutritional supplements by patients suffering with various medical conditions. These soft gel capsules are usually free of genetic modifications and are manufactured adhering to strict quality standards. The soft gel capsules are available in gelatin as well as non-gelatin composition for people with vegetarian and non-vegetarian preferences. The soft gels are one of the most common and widely used oral dosage form of pharmaceuticals as well as nutraceuticals. The starch softgel capsules market is expected to witness huge growth due to increasing availability of vegetarian softgel capsules. However, the difficulties in optimizing cellulose/starch for API delivery may hinder the growth of market.
Market Overview and Dynamics
The Europe starch softgel capsules market is projected to reach US$ 114.85 million by 2027 from US$ 161.36 million in 2019. The market is anticipated to grow with a CAGR of 4.5% from 2020 to 2027. Factors driving the market growth include increasing availability of vegetarian softgel capsules and growing spending & consumption on health supplements. However, the difficulties in optimizing cellulose/starch for API delivery is likely to have a negative impact on the market growth.
Key Market Segments
Based on application, the health supplement segment accounted for a larger share of the Europe starch softgel capsules market in 2019. In terms of distribution channel, the pharmacy and drugstore segment held a larger share of the starch softgel capsulesmarket in Europe.
Major Sources
A few major primary and secondary sources referred to while preparing the Europe starch softgel capsules market report are World Health Organization, Pharmaceutical Research and Manufacturers of America, and Council for Responsible Nutrition.
Reasons to buy the report
- To understand the Europe starch softgel capsules market landscape and identify market segments that are most likely to guarantee a strong return
- To stay ahead in comprehending the ever-changing competitive landscape of the Europe starch softgel capsules market
- To efficiently plan M&A and partnership deals in the Europe starch softgel capsules market by identifying market segments with the most promising probable sales
- To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Europe starch softgel capsules market
- To obtain market revenue forecast from 2019 to 2027 in various segments of the Europe starch softgel capsules.
EUROPE STARCH SOFTGEL CAPSULES MARKET SEGMENTATION
By Application
- Pharmaceutical
- Health Supplements
- Others
By Distribution Channel
- Supermarket and Hypermarket
- Pharmacy and Drugstore
- Online Provider
By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Catalent Inc
- Robinson Pharma, Inc
- ProCaps
- CAPTEK Softgel International Inc
- Sirio Pharma Co
Europe Starch Softgel Capsules Market Forecast to 2027 – Covid-19 Impact and Analysis – by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider)
Pages: 100
Market Introduction
The starch softgel capsules are usually derived from natural sources and used as nutritional supplements by patients suffering with various medical conditions. These soft gel capsules are usually free of genetic modifications and are manufactured adhering to strict quality standards. The soft gel capsules are available in gelatin as well as non-gelatin composition for people with vegetarian and non-vegetarian preferences. The soft gels are one of the most common and widely used oral dosage form of pharmaceuticals as well as nutraceuticals. The starch softgel capsules market is expected to witness huge growth due to increasing availability of vegetarian softgel capsules. However, the difficulties in optimizing cellulose/starch for API delivery may hinder the growth of market.
Market Overview and Dynamics
The Europe starch softgel capsules market is projected to reach US$ 114.85 million by 2027 from US$ 161.36 million in 2019. The market is anticipated to grow with a CAGR of 4.5% from 2020 to 2027. Factors driving the market growth include increasing availability of vegetarian softgel capsules and growing spending & consumption on health supplements. However, the difficulties in optimizing cellulose/starch for API delivery is likely to have a negative impact on the market growth.
Key Market Segments
Based on application, the health supplement segment accounted for a larger share of the Europe starch softgel capsules market in 2019. In terms of distribution channel, the pharmacy and drugstore segment held a larger share of the starch softgel capsulesmarket in Europe.
Major Sources
A few major primary and secondary sources referred to while preparing the Europe starch softgel capsules market report are World Health Organization, Pharmaceutical Research and Manufacturers of America, and Council for Responsible Nutrition.
Reasons to buy the report
- To understand the Europe starch softgel capsules market landscape and identify market segments that are most likely to guarantee a strong return
- To stay ahead in comprehending the ever-changing competitive landscape of the Europe starch softgel capsules market
- To efficiently plan M&A and partnership deals in the Europe starch softgel capsules market by identifying market segments with the most promising probable sales
- To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Europe starch softgel capsules market
- To obtain market revenue forecast from 2019 to 2027 in various segments of the Europe starch softgel capsules.
EUROPE STARCH SOFTGEL CAPSULES MARKET SEGMENTATION
By Application
- Pharmaceutical
- Health Supplements
- Others
By Distribution Channel
- Supermarket and Hypermarket
- Pharmacy and Drugstore
- Online Provider
By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Catalent Inc
- Robinson Pharma, Inc
- ProCaps
- CAPTEK Softgel International Inc
- Sirio Pharma Co
Europe Starch Softgel Capsules Market Strategic Insights
Europe Starch Softgel Capsules Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 161.36 Million |
| Market Size by 2027 | US$ 114.85 Million |
| CAGR (2020 - 2027) | 4.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Application
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Starch Softgel Capsules Market Country and Regional Insights
